Oncologie Closes an $80M Series B Financing for Clinical-Stage Pipeline

BOSTON, June 10, 2019 -- (Healthcare Sales & Marketing Network) -- Oncologie, an innovative biopharmaceutical company using proprietary biomarkers to drive clinical development of next-generation oncology therapeutics, announced today that it has closed a... Biopharmaceuticals, Oncology, Venture Capital Oncologie, bavituximab
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news